Stefano Pileri mostly deals with Lymphoma, Pathology, Internal medicine, Cancer research and Immunology. His Lymphoma study combines topics in areas such as Peripheral T-cell lymphoma, Germinal center and Survival analysis. His work carried out in the field of Germinal center brings together such families of science as Molecular biology, Diffuse large B-cell lymphoma, Antigen and Virology.
His Pathology research is multidisciplinary, incorporating elements of Cancer, Large cell and B cell. His Internal medicine research incorporates elements of Gastroenterology, Surgery and Oncology. His Cancer research study combines topics from a wide range of disciplines, such as Gene expression profiling, Mutation, Anaplastic lymphoma kinase, Anaplastic large-cell lymphoma and Leukemia.
His scientific interests lie mostly in Pathology, Lymphoma, Internal medicine, Cancer research and Immunology. Stefano Pileri combines subjects such as Immunophenotyping and B cell with his study of Pathology. His Lymphoma research is multidisciplinary, incorporating perspectives in Peripheral T-cell lymphoma and T cell.
His Internal medicine research includes themes of Gastroenterology, Surgery and Oncology. The various areas that Stefano Pileri examines in his Cancer research study include Mutation, Leukemia and Gene expression, Gene expression profiling. Stefano Pileri interconnects Myeloid and Myeloid leukemia in the investigation of issues within Leukemia.
Lymphoma, Internal medicine, Cancer research, Oncology and Pathology are his primary areas of study. His work deals with themes such as Peripheral T-cell lymphoma, B cell and Gene expression profiling, which intersect with Lymphoma. His studies link Surgery with Internal medicine.
Within one scientific family, Stefano Pileri focuses on topics pertaining to T cell under Cancer research, and may sometimes address concerns connected to T-cell lymphoma. His biological study spans a wide range of topics, including Prospective cohort study, Chemotherapy, ABVD and CD8. His research is interdisciplinary, bridging the disciplines of BCL6 and Pathology.
His main research concerns Internal medicine, Lymphoma, Oncology, Cancer research and Pathology. In Internal medicine, Stefano Pileri works on issues like Surgery, which are connected to Hazard ratio. His work in the fields of Lymphoma, such as Anaplastic large-cell lymphoma, intersects with other areas such as Diagnostic algorithms.
His Anaplastic large-cell lymphoma research focuses on Tumor marker and how it relates to Immunology. Stefano Pileri has researched Cancer research in several fields, including Gene expression profiling, Venetoclax, Regulation of gene expression, Gene and CD20. His Pathology research is multidisciplinary, incorporating perspectives in BCL6, B cell, Hematopathology and Follicular dendritic cells.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow;Elias Campo;Stefano A. Pileri;Nancy Lee Harris.
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.
Elias Campo;Steven H. Swerdlow;Nancy L. Harris;Stefano Pileri.
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Harald Stein;Hans-Dieter Foss;Horst Dürkop;Theresa Marafioti.
BRAF mutations in hairy-cell leukemia
Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes.
The New England Journal of Medicine (2011)
ALK - anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage;Nancy Lee Harris;Julie Marie Vose;Fred Ullrich.
Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections
Giorgio Cattoretti;Stefano Pileri;Carlo Parravicini;Michael H. G. Becker.
The Journal of Pathology (1993)
ALK+ Lymphoma: Clinico-Pathological Findings and Outcome
Brunangelo Falini;Stefano Pileri;Pier Luigi Zinzani;Antonino Carbone.
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases
S. A. Pileri;T. M. Grogan;N. L. Harris;P Banks.
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Massimo Federico;Monica Bellei;Luigi Marcheselli;Stefano Luminari.
Journal of Clinical Oncology (2009)
WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.
E Sabattini;F Bacci;C Sagramoso;S A Pileri.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: